Class of 2026
For revered contributions to demonstrating how microbiome composition and innate immunity shape clinical outcomes following immunotherapy, including microbial predictors of PD-1 response, exosome-based vaccine strategies, and mechanisms of immunogenic cell death as well as biomarkers to guide checkpoint inhibitor efficacy in melanoma.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]